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Retroviral transformation has been associated with pro-proliferative oncogenic signaling in human cells.
The current study demonstrates that transduction of human breast carcinoma cells (MDA-MB231) with
LXSN and QCXIP retroviral vectors causes signiﬁcant increases in growth rate, clonogenic fraction, and
aldehyde dehydrogenase-1 positive cells (ALDH1þ), which is associated with increased steady-state
levels of cancer stem cell populations. Furthermore, this retroviral-induced enhancement of cancer cell
growth in vitro was also accompanied by a signiﬁcant increase in xenograft tumor growth rate in vivo.
The retroviral induced increases in cancer cell growth rate were partially inhibited by treatment
with 100 U/ml polyethylene glycol-conjugated-(PEG)-superoxide dismutase and/or PEG-catalase. These
results show that retroviral infection of MDA-MB231 human breast cancer cells is capable of enhancing
cell proliferation and cancer stem cell populations as well as suggesting that modulation of reactive
oxygen species-induced pro-survival signaling pathways may be involved in these effects.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Introduction
The transforming qualities of retroviruses have been appre-
ciated for over a century [1]. Although the speciﬁc nature of
mechanisms involved in retroviral infection was not appreciated
until 1970 with the identiﬁcation of reverse transcriptase, they had
already been implicated in the initiation and promotion of many
cancers in animals [1,2]. Their role in human cancers has only
begun to be appreciated in more recent years. Indeed, although
the mechanism(s) are not always clear, the origin of 15–20% of
human cancers may be linked to cellular transformation by a virus
[1]. Human T-cell leukemia virus type I (HTLV-1) was the ﬁrst
human transforming retrovirus discovered [3]. Some of the mole-
cular mechanisms governing cellular transformation by retro-
viruses have been elucidated, including insertional mutagenesis,
introduction of viral oncogenes into the host DNA, and chronic
inﬂammation associated with oxidative stress [4–6]. Nevertheless
there are many examples where the mechanism(s) governing
retrovirus-associated cellular transformation remain a mystery.
Although there is an association between retroviral infection
and cancer, retroviral infection itself does not typically result in
the formation of cancer within an individual. Nevertheless, viral
infections have been associated with increased ﬂuxes of reactive
oxygen species (ROS) such as superoxide (O2) and hydrogen
peroxide (H2O2) in infected cells [7,8]. Furthermore it has been
hypothesized with signiﬁcant supporting data that increased
steady-state levels of ROS in cells contributes to initiation, promo-
tion, and progression of cancers [9–12]. Recent work has identiﬁed
increases in ROS in response to experimental viral vector infection
in vitro [13,14]. Zhang et al. [13] found that infection of murine
liver cells in vivo, with a replication defective adenovirus caused
increased oxidative stress and caused increased AP-1 binding to
DNA, and a reduction in the GSH/GSSH ratio indicative of thiol
oxidation. AP-1 is considered a redox regulated stress-responsive
transcription factor [15] and this previous report went on to show
that adenoviral-based overexpression of manganese superoxide
dismutase (MnSOD) diminished viral-induced AP-1 activation and
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restored the GSH/GSSH ratio to physiological levels, implicating
superoxide (O2) and H2O2 as causative agents in viral effects on
signal transduction. In a separate study, Piccoli et al. [14] identiﬁed
a defect in mitochondrial electron transport chain complex I that
caused excess ROS buildup in human mesenchymal stem cells
after transformation with several empty retroviral vector back-
bones. The levels of intracellular perturbations in the redox
environment in these two studies were sub-lethal and the
mechanisms linking viral infection to increased ROS generation
were not speciﬁcally investigated.
ROS mediate various physiological and pathophysiological
cellular responses depending on the cell type affected and
the level of intracellular redox perturbation that is imposed
[10,16–20]. Low levels of ROS serve as important signaling mole-
cules utilized in processes such as growth factor response, and
protein modiﬁcations including phosphorylation and sumoylation
[16]. Higher levels of ROS are used for immune signaling and
apoptosis [21].
The work presented in the current studies describes signiﬁcant
pro-growth responses induced by infection of human mammary
adenocarcinoma cells with two different retroviral vectors, LXSN
and QCXIP. The pro-growth phenotypic changes are accompanied
by signiﬁcant increases in steady-state levels of pro-oxidants as
determined by increases in CDCFH2 oxidation, accelerated cell
growth rate, and an increase in the number of cancer cells
expressing ALDHþ activity that indicates an increase in cancer
stem cell populations. The retroviral induced increases in cancer
cell growth rate were partially inhibited by treatment with
polyethylene glycol-conjugated-(PEG)-superoxide dismutase and/
or PEG-catalase. The current work provides the ﬁrst evidence of a
causal link, in the absence of an exogenous viral onco-protein,
between retroviral infection and excess generation of pro-oxidants
leading to a pro-survival, pro-growth phenotype in human breast
cancer cells.
Materials and methods
Cell culture
The MDA-MB231 metastatic human breast cancer cell line was
obtained from the ATCC [22]. MDA-MB231 and the retrovirally
transformed derivatives of this cell line (MDA-MB231-LXSN and
MDA-MB231-QCXIP), were grown in 10 cm tissue culture dishes at
37 1C, 5% CO2, in RPMI 1640 (Gibco, Life Technologies) supplemen-
ted with 10% fetal bovine serum (FBS) (Atlanta Biologicals), 100 U/
ml penicillin and 100 mg/ml streptomycin (pen-strep, Gibco, Life
Technologies). GP293 (Clontech) cells were grown at 37 1C, 5% CO2,
in Dulbecco Modiﬁed Eagle Medium, High-Glucose (Gibco, Life
Technologies) supplemented with 10% FBS, 100 U/ml penicillin and
100 mg/ml streptomycin.
Generation of retroviral vectors
The retroviral expression vectors utilized in this study were the
LXSN-neomycin resistance gene (NeoR) expression vector [23] and
the pOCXIP-puromycin resistance gene (Pur) expression vector
(Clontech). The LXSN-NeoR vector was a generous gift from
Dr. Aloysius Klingelhutz (Department of Microbiology, University
of Iowa).
Retroviral transduction
The LXSN-NeoR vector and pQCXIP-Puro retroviral vectors
were transfected alongside a VSVg expression vector into GP293
cells using the calcium-phosphate method [24]. Twelve
micrograms of both the retroviral vector and the VSVg expression
vector were used in the transfection procedure. The media was
changed at 4 and 24 hours post-transfection and cells were then
allowed to produce viral particles for an additional 24 hours. The
viral supernatant was collected, ﬁltered and applied to 10 cm
dishes containing 1106 MDA-MB231 cells overnight with 16 m
g/ml of Polybrene to enhance viral transduction. Antibiotic selec-
tion was begun 48 hours after infection. LXSN-NeoR transformants
were selected with 800 mg/ml Geneticin (Gibco, Invitrogen) for
14 days. pQCXIP transformants were selected in 2 mg/ml of
Puromycin (Sigma) for 7 days.
Clonogenic assay
Two hundred ﬁfty cells were plated on 60mm tissue culture
dishes. Cells were allowed to grow at 37 1C for 14 days in RPMI, 10%
FBS, 1% pen-strep. On day 14, cells were rinsed with PBS, ﬁxed
with ice cold 100% methanol, and stained with crystal violet for 10
min (0.5% crystal violet in 25% methanol). The plates were then
rinsed with water, imaged using a Typhoon FLA 7000 (General
Electric) and the number of colonies were counted using ImageJ
software (National Institutes of Health, Bethesda). In experiments
where the individual cells were counted along with colonies, the
plates were rinsed with PBS and stained immediately without
ﬁxation in 0.5% crystal violet in the absence of methanol. The
plates were rinsed gently with water and imaged using a Typhoon
FLA 7000 for quantiﬁcation using ImageJ software. After imaging,
cells were trypsinized and counted using a Z1 Coulter Particle
Counter (Beckman Coulter). Each plate was counted twice and the
average of the counts was used to determine the overall cell
number. Results are presented as the number of cells divided by
the number of colonies for each plate.
Growth rate analysis
Cells were plated at 2500 cells/cm2 in RPMI 1640 (10% FBS,
pen-strep) at 0 hours. Every 24 hours after seeding, cells were
trypsinized and counted on a Z1 Coulter Particle Counter. Each
well was counted twice and the average of the two counts was
plotted over time.
Estimation of cancer stem cells using Aldeﬂuor assay
Cells were grown and treated as described above. After trypsi-
nizing, cells were washed in DPBS and counted. 1106 cells were
re-suspended in 1ml of ALDEFLUOR assay buffer and assayed
following kit directions (Stem Cell Technologies). Brieﬂy, 5 ml
Aldehyde dehydrogenase substrate (BODIPY-aminoacetaldehyde)
was added to each tube. Immediately after addition, 500 ml was
transferred to a tube containing 5 ml dimethylaminobenzaldehyde
(DEAB), an inhibitor of ALDH. Cells were incubated for 40min at
37 1C and then washed in kit buffer containing an efﬂux inhibitor.
Hoechst 33342 was added for viability and samples kept on ice for
analysis by using a Becton, Dickinson LSR II with 355, 488 and 633
nm lasers (Becton, Dickinson and Company). The percentage ALDH
positive cells of approximately 100,000 cells counted was deter-
mined by using the sorting gate established with Hoechst for
viability and DEAB for the negative control.
Fluorescence probe labeling for alterations in pro-oxidants
Cells were washed with PBS and resuspended in 1 ml of PBS
with glucose (pH 7.4). 10 mg/ml of the oxidation sensitive 5-(and-
6)-carboxy-20,70-dichlorodihydroﬂuorescein diacetate (CDCFH2;
C-400 Molecular Probes Inc.) or oxidative insensitive 5-(and-6)-
carboxy-20,70-dichloroﬂuorescein diacetate (CDCF; C-369 Mole-
L.J. Wegman-Points et al. / Redox Biology 2 (2014) 847–854848
cular Probes), were then added to the appropriate treatment
conditions. DMSO (dye vehicle) treated unstained cells were used
to correct for auto-ﬂuorescence, whereas 10 micromoles Antimy-
cin A was used as a positive control for increasing probe oxidation.
Cells were then incubated with the probe for 15min (CDCFH2)
before analysis with LSR-VIOLET ﬂow cytometry. Excitation/emis-
sion wavelengths for CDCFH2 were 488 nm/530 nm. Roughly
10,000 counts were gated per sample, and the mean of three
samples was calculated for each treatment. The negative control
(background ﬂuorescence) was subtracted from each of the
sample averages and then each sample was normalized to the
control (uninfected) sample, to yield the mean ﬂuorescent inten-
sity (MFI) for each sample.
PEG-catalase and PEG-SOD treatment
Cells were treated with 100 U/ml of PEG-catalase and/or PEG-
SOD at the time of plating for the growth rate analysis.
In vitro tumor growth
The nude mice protocol was reviewed and approved by the
Animal Care and Use Committee of the University of Iowa.
Exponentially growing MDA-MB231, MDA-MB231-LXSN, and
MDA-MB231-QCXIP cells were gently trypsinized (TrypLE, Life
Technologies) and resuspended in sterile PBS at 2107/ml.
The cells were mixed at a ratio of 1:1 with Matrigel. Female
(8–10 weeks) athymic nu/nu mice (Harlan, Sprague) were
subcutaneously injected with 100 ml (1106) of MDA-MB231 (left
ﬂank) and MDA-MB231-LXSN or MDA-MB231-QCXIP (right ﬂank).
After visible tumors were identiﬁed, they were measured every
72–96 hours or weekly with a caliper. Measurements were over
5 weeks, or until the tumor became too large whereupon the
mouse was euthanized. Tumor volume was determined by the
equation: π(LW2) /6 as previously described [15].
Results
Retroviral transfection enhances breast cancer cell growth
and alters cell morphology
Through retroviral infection and antibiotic selection of the
MDA-MB231 breast cancer cell line, we generated populations
with either the LXSN (MDA-MB231-LXSN) or the pQCXIP (MDA-
MB231-QCXIP) retroviral vector stably integrated into the genome
which was conﬁrmed by antibiotic selection. We examined the
clonogenic capacity of the transformed cell lines. We found an
almost 2-fold increase in the clonogenic survival fraction of both
the MDA-MB231-LXSN and MDA-MB231-QCXIP lines when com-
pared to the parental cell line (Figs. 1A, D, G and 2A). We also saw
evidence of reduced contact inhibition within the colonies ana-
lyzed. The colonies examined were both larger and denser than
those seen in MDA-MB231 (Fig. 1B, E and H). The retroviral
transformed cell lines appeared to be growing both out to the
periphery of the colonies and on top of one another, whereas the
MDA-MB231 colonies appeared to expand out peripherally (Fig. 1E
Fig. 1. Retroviral infection alters the colony appearance and morphology of MDA-MB-231 human mammary adenocarcinoma cells. (A), (D), and (G)—representative images
of clonogenic assay plates from untransformed MDA-MB231 cells (A), retrovirally transformed cells MDA-MB231-LXSN (D), and MDA-MB231-QCXIP (G). Cells were seeded at
the density of 250 cells/60 mm dish and allowed to form colonies for 14 days where cells were ﬁxed and stained. (B), (E), and (H) higher magniﬁcation images of a single
colony highlighting the piling up of cells in the colonies of the MDA-MB231-LXSN (E) and MDA-MB231-QXCIP (H) versus the single layer of cells characteristic of the MDA-
MB231 colonies (B). (C), (F), and (I)—close-up images showing the distinct morphological differences between the parent MDA-MB231 (C) cells and the transformed lines
MDA-MB231-LXSN (F) and MDA-MB231-QCXIP (I).
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and H). To quantify this phenotype we counted the number of cells
per colony. As expected, the MDA-MB231-LXSN and MDA-MB231-
QCXIP cell lines had three and ﬁve times the number of cells per
colony, respectively (Fig. 2B). As shown in Fig. 2C, MDA-MB231-
LXSN and MDA-MB231-QCXIP both also demonstrated signiﬁ-
cantly reduced doubling times when compared to MDA-MB231,
reinforcing the conclusion that the retroviral transformed cells
were expressing a pro-growth/pro-survival phenotype, relative to
the control non-virally infected cells.
Retroviral transformation induces phenotypic changes
In addition to an increase in clonogenic survival and growth
rate, the morphology of the MDA-MB231-LXSN and MDA-MB231-
QCXIP cell lines was different from that of the parental MDA-
MB231. We observed alterations in both the size and the appear-
ance of the cell bodies as compared to their parental line. MDA-
MB231 cells had an elongated phenotype (Fig. 1C) while Both
MDA-MB231-LXSN and MDA-MB231-QCXIP had larger cell bodies
and a more epithelial appearance than their parental cell line
(Fig. 1F and I). In addition to these changes in morphological
appearance, the virally transformed cells appeared to lose some
contact inhibition characteristics (Fig. 1BC, EF, HI). When grown to
conﬂuence MDA-MB231 cells would not grow as dense in the
center of the colony (Fig. 1BC). However MDA-MB231-LXSN and
MDA-MB231-QCXIP continued to divide upon reaching conﬂuence
and as a result formed multiple layers of cells within a single
colony (Fig. 1EF and HI).
Retroviral transformed breast cancer cells contain an in increased
sub-population of cells with enhanced ALDH activity
To examine the possibility that retroviral transformation had
stimulated growth of an early progenitor cancer stem cell
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Fig. 2. Retroviral infection alters the clonogenic capacity, growth rate, and ALDH1 stem cell markers of MDA-MB231 cells. (A) Clonogenic survival fraction of the cell lines
analyzed. After 14 days of seeding at a density of 250cells/60mm dish, cells were ﬁxed, stained, and surviving colonies were then counted. (B) Graph displaying the number
of cells per colony of the untransformed cells (MDA-MB231) versus the retrovirally transformed lines (MDA-MB231-LXSN and MDA-MB231-QCXIP). (C) Cell doubling time (in
hours) of cell lines. All transformed cell lines maintained a shorter doubling time than the parental cell lines. (D) Bar graph charting the increases in % population of
transformed cells displaying ALDEFLUOR activity. 1106 cells were re-suspended in ALDEFLUOR assay buffer as recommended by the manufacturer. Samples were analyzed
by ﬂow cytometer. The number of ALDH positive cells of 100,000 live cells was determined by using the sorting gate established using DEAB the ALDH1 inhibitor containing
samples. A minimum of 10,000 cells was analyzed from each cell population. P values were calculated using two-sided Student’s t test.
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Fig. 3. Retroviral infection increases the oxidation of CDCFH2 in MDA-MB231 cells
indicating a shift in the intracellular redox environment. Left side: transformed
cells (MDA-MB231-LXSN and MDA-MB231-QCXIP) signiﬁcantly increased CDCFH2
oxidation, relative to MDA-MB231. Right side: when the cells were labeled with the
oxidation insensitive probe, CDCF, no difference was seen in the ﬂorescence of the
probe between cell lines indicating that the changes in ﬂorescent seen in panel A
were caused by changes in probe oxidation.
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population, we examined the parental and transformed popula-
tions for the percentage of aldehyde dehydrogenase 1 positive
cells (ALDH1þ) using an ALDH activity assay. The ALDH family of
enzymes oxidizes intracellular aldehydes to carboxylic acids in
early progenitor cancer stem cells [25]. A higher percentage of
ALDH1þ cells in breast cancer cell populations is a predictor of
poor clinical outcome and in animal models ALDH1þ cancer cells
form large tumors faster with fewer cells injected, indicating an
aggressive pro-growth/survival phenotype [26,27]. Using the
ALDEFLUOR assay to quantify the percentage of cells expressing
ALDH1 activity we found that retrovirally infected MDA-MB231
populations, showed a dramatic increase in the number of
ALDH1þ cells (Fig. 2D). These results suggest that the retrovirally
transformed cell populations contained a higher percentage of
early progenitor cancer stem cells, relative to the parental cell
population that could contribute to an aggressive growth
phenotype.
Retrovirally transformed cells show higher steady-state levels
of CDCFH2 oxidation
To determine if changes in the intracellular redox environment
of the retrovirally transformed cells could contribute to the pro-
growth phenotype, the oxidation of CDCFH2 was measured and
compared to the ﬂuorescence seen when the same cells were
labeled with the oxidation insensitive analog (CDCF). As can be
seen in Fig. 3 (left side), a 2.5 fold increase in the mean
ﬂuorescence intensity of both the MDA-MB231-LXSN and MDA-
MB-231-QCXIP populations was noted when the cells were labeled
with the oxidation sensitive CDCFH2, compared to non-infected
MDA-MB231. This is in contrast to the lack a change in ﬂuores-
cence in the same cell lines labeled with the oxidation-insensitive
analog CDCF (Fig. 3, right side) showing that changes in ﬂuores-
cence were attributable to changes in the dye oxidation and not
changes in uptake, ester cleavage, or efﬂux of the probe. These
results demonstrate a shift to a more pro-oxidant intracellular
redox environment in the virally infected cells, relative to controls,
that could be contributing to the more aggressive pro-growth
phenotype.
PEG-catalase and PEG-SOD inhibited the growth
of the transformed cells
To further probe the involvement of changes in the intracellular
redox environment mediated by superoxide (O2) and hydrogen
peroxide (H2O2) in the observed retroviral-induced phenotypic
changes, we treated cells with 100 U/ml of PEG-CAT that is known
to scavenge H2O2 and/or PEG-SOD that is known to scavenge O2 .
As shown in Fig. 4, left panel, when treated with both PEG-CAT
and/or PEG-SOD, MDA-MB231-LXSN cells exhibited an increased
cell doubling time, close to that of MDA-MB231 uninfected cells. In
addition the experiments with the MDA-MB231-QCXIP showed
that neither of PEG-conjugated enzymes alone produced a sig-
niﬁcant effect on cell growth in the retroviral infected cells but
when used in combination, a signiﬁcant increase in the doubling
time was observed (Fig. 4, right panel). These data support the
hypothesis that changes in the intracellular redox environment of
retroviral infected cells mediated by O2 and H2O2 signiﬁcantly
contribute to the pro-growth pro-survival phenotype seen follow-
ing infection.
Retrovirally transformed MDA-MB231-LXSN and MDA-MB231-QCXIP
cells are more tumorigenic in vivo
To determine if the accelerated growth and increase in
ALDHþ cells observed in vitro translated into more aggressive
growth in an in vivo model, we injected equal numbers of
MDA-MB231, MDA-MB231-LXSN, and MDA-MB231-QCXIP into
athymic nu/nu mice and monitored tumor growth. To control
for differences among animals, each mouse was injected with
uninfected and virally infected cell lines on opposing ﬂanks.
Measurable tumors were observed after one-two weeks.
Fig. 5A illustrates the substantial differences in tumor size
induced by MDA-MB231-LXSN after 5 weeks of growth on the
right ﬂank versus the smaller MDA-MB231 tumors on the left
ﬂank. The differences in tumor volume in ﬁve animals per
group are quantiﬁed in Fig. 5B. At day 29, the average of the
MDA-MB231-LXSN tumor volume was over ten-fold that of the
MDA-MB231 tumors (8247368 mm3 and 7179 mm3, respec-
tively). Similar increases in in vivo growth were also observed
with the MDA-MB231-QCXIP cell line, when compared to the
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side: population doubling time of MDA-MB231 QCXIP cells when treated with PEG-catalase, PEG-SOD, or both.
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parental MDA-MB231 (Fig. 5C) although the rate of tumor
growth was less than the rate observed in MDA-MB231-LXSN.
Fig. 5B and C show that retroviral transformation resulted in
signiﬁcantly increased tumor growth in vivo when compared to
the parental MDA-MB231. This data supports the conclusion
that the signiﬁcant differences in pro-growth and pro-survival
effects of the retroviral infection in vitro also translated into
signiﬁcant increases in tumor growth in vivo.
Discussion
Retroviral vectors have become extremely useful tools for gene
transfer in molecular biology, both in vitro and in vivo [23,28].
With the proper conditions, their integration efﬁciency can
approach 100%. However, these tools are not without their own
set of limitations. Retroviral vector infection has been shown to
cause cancerous cellular transformation. In two independent trials,
retroviral vector-based gene therapy caused leukemia in a sig-
niﬁcant subpopulation of children treated for SCID-IX [29,30]. This
unfortunate consequence of the treatment was linked to a com-
mon area of integration surrounding the proto-oncogene, lom2,
causing activation and cellular transformation of T-cells [29].
Activation of the proto-oncogene no doubt contributed to the
cellular transformation in the SCID-IX cases, however cancer is a
multi-step process that cannot be deﬁned by a single cellular
disruption [31]. While viruses have been identiﬁed in 15–20% of
human cancers, other factors contribute to differential suscept-
ibility of individuals to cancer initiation or progression by retro-
viral infection.
Retroviruses can contribute to cancer initiation or progression
through insertional mutagenesis, as described above, affecting the
expression of a gene, often one critical to cell-cycle regulation [29].
Another potential contributing factor includes the expression of a
viral oncogene, carried within the viral genome, one that often
disrupts the activity of the host cell cycle. In our case, retroviral
infection led to the progression of already malignant cells by
increasing their growth rate and tumorigenicity. While we have
yet to elucidate the exact mechanism responsible, several factors
allow us to speculate on the mechanisms involved.
The ﬁrst potential mechanism, insertional mutagenesis, we
believe to be an unlikely explanation for our experimental results.
We observed an identical phenotype using two independent
retroviral vectors, each with different viral backbones. Each class
of retrovirus, and their respective retroviral vectors, has their own
distinct trend in integration site selection [29]. LXSN is a MoMLV
based retroviral vector, MoMLV viruses incorporate in 50 transcrip-
tion units and CpG islands [24,32]. pQCXIP is derived from MSV
which directs integration towards areas of compacted chromatin.
However, it should be noted that these trends can be affected not
only by the host DNA sequence, but also by the viral integrase (IN).
Lewinski et al. [33] recently showed that the viral integrase may
have a larger role in directing the integration site than originally
proposed. The authors were able to alter the integration pattern of
HIV closer to that of an MLV by supplying an MLV-based integrase.
In our experiments, both retroviral backbones utilized the same
integrase, a MoMLV based IN from the GP293 packaging line,
opening up the potential for similar integration sites.
Retroviruses only succeed at stable integration and pro-viral
propagation in dividing cell populations due to their inability to
cross the intact nuclear envelope. Thus we may have selected cells
with a greater reproductive future via retroviral integration and
selection. This idea is supported by the fact that MDA-MB231 cells
infected with the FIV lentivirus, which can cross the nuclear
envelope and infect both dividing and non-dividing cells, did not
cause the phenotype generated by the non-lenti retroviral vectors
(Supplemental Fig. 1). We ﬁnd this scenario unlikely however, due
to the fact that the MDA-MB231 cells were in a period of
exponential growth at the time of infection. Because of this, the
vast majority of the cells were in some stage of division during the
window of infection and therefore susceptible to retroviral infec-
tion, arguing against the idea that we selected for some subset of
the population.
An additional possibility for a mechanism underlying the pro-
growth phenotype elicited by retroviral infection was the disrup-
tion of intracellular redox homeostasis as detected by signiﬁcant
Fig. 5. Retroviral transfection of MDA-MB231 enhances xenograft tumor growth
rate in nude mice. (A) One million cells were subcutaneously injected into the left
(MDA-MB231) and right (MDA-MB231-LXSN) ﬂanks of 6–8 weeks old athymic nu/
nu mice. (B) Tumor growth was monitored and measured with a caliper for
5 weeks after injection. N ¼ 5 mice. (C) In a separate experiment, one million cells
of MDA-MB231 and MDA-MB231-QCXIP were subcutaneously injected into the left
and right ﬂank, respectively of 6–8 weeks old athymic nu/nu mice. Tumor growth
was monitored and measured with a caliper for a period of 10 weeks. N ¼ 4 mice.
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changes in CDCFH2 oxidation that were noted in both retroviral
transformed cell lines. However, the CDCFH2 assay is not speciﬁc
for any pro-oxidant species and can detect changes in redox active
metal ions, peroxidase enzymes, reactive nitrogen species, and
reactive oxygen species. To determine if changes in steady-state
levels of O2 and H2O2 might be contributing to any of the
biological effects seen with retroviral infection, cells were treated
with PEG-SOD and PEG-CAT which caused reduced in vitro cell
growth as determined by signiﬁcantly longer cell doubling times.
Since these enzymes are speciﬁc for scavenging O2 and H2O2,
these results provide evidence supporting the hypothesis that the
pro-growth pro-survival phenotype seen following retroviral
infection is at least partially mediated by increased steady-state
levels of pro-oxidants derived from O2 and H2O2. However the
exact source of this apparent metabolic perturbation in intracel-
lular redox reactions in our retroviral infection system is currently
not known.
Several previous reports have demonstrated increases in
steady-state levels of intracellular ROS in response to viral infec-
tion; however the precise mechanisms have not been deﬁned. One
possibility for viral induced redox perturbations was suggested by
Piccoli et al. [14]. They suggested that the overexpression of the
antibiotic selection genes, Neo-R and PAC for LXSN and pQCXIP
respectively are responsible for a decrease in mitochondrial
electron transport chain Complex I functionality, and the subse-
quent increase in ROS [14]. Each retroviral vector used in the
current study expresses a single exogenous gene, used in the
antibiotic selection process. LXSN expresses NeoR, an aminoglyco-
side phosphotransferase that confers resistance to the aminoglyco-
side Geneticin [34]. pQCXIP expresses PAC, an acetyltransferase
that allows transcription in the presence of Puromycin [35]. These
two selection proteins add unique moieties to their individual
targets, making it unlikely to cause the same phenotype within a
cell line. While NeoR is part of a family that has been shown to
have protein kinase activities, its expression has never been linked
to any effects on cell growth or malignancies [36,37]. We did
address this possibility by performing stable transfections of MDA-
MB-231 cells with both pcDNA3.1-Neo and LXSN using Lipofecta-
mine, bypassing the retroviral infection process, and no signiﬁcant
effects on growth, clonogenicity (Supplemental Fig. 1) or redox
homeostasis were noted.
Finally, we noted an increased level of ALDH1 expression, as
evidenced by an increase in ALDEFLUOR activity, in the trans-
formed cell lines. ALDH1 expression is considered a putative stem
cell marker. Recent interest has surrounded the identiﬁcation of
potential cancer stem cells (CSC), as a subpopulation of cells
within a tumor that are capable of not only propagation, but
self-renewal as well. In 2007, Ginestier et al. proposed that ALDH1
can be used to identify mammary CSCS and can be used as a
predictor of poor clinical outcome [26]. Indeed, several studies
examining the expression of ALDH1 have shown this marker to be
linked to poor prognosis and reduced long-term survival in breast
cancer patients [38]. However, other studies have failed to ﬁnd a
link between ALDH1 and survival [39]. Recently, Charafe-Jauffret
et al. was able to link increased ALDEFLUOR activity in human
breast cancer biopsies to both better xenotransplantation potential
and increased metastasis [40]. They were able to show that
populations selected for ALDEFLUOR activity showed not only an
increased xenograft success rate in mice, but increased growth
rates within the animal as well. They were also able to link
ALDEFLUOR activity to an increase in gene expression consistent
with a stem cell signature. In accordance with these recent
ﬁndings, both of our transformed MDA-MB231 populations
showed dramatic increases in ALDEFLUOR activity coupled with
an increased growth rate in mouse xenografts. The rate of growth
did not correlate exactly with the degree of ALDEFLUOR activity,
however a larger sample size may be able to associate these two
outcomes more closely.
Both normal and cancer cells are vulnerable to retroviral
infection and potential transformation. As stated before, 15–20%
of cancers can be linked to a viral infection, though often the direct
mechanism of transformation is unclear. In our case, there appears
to be something unique about the MDA-MB231 cell line that
makes it particularly vulnerable to retroviral transformation into a
more aggressive phenotype. Several other mammary cell lines,
both normal (MCF-10A) and cancerous (MCF-7 5C and BT549),
did not show the dramatic phenotypic transformation properties
when infected with our retroviral constructs (Supplemental Fig. 2).
It should be noted that a slight increase in clonogenic fraction was
seen in MCF-7 5C after retroviral infection, but none of the other
phenotypes seen in MDA-MB231 were observed. Our results did
not appear to be linked to the absence of estrogen receptors (ER)
in MDA-MB231 cells, as other ER negative cell lines (MCF10A and
BT549) did not show the same results. Future directions should
include the identiﬁcation of what distinctive factor(s) make this
particular cell line susceptible to retroviral transformation into an
even more aggressive form of breast cancer.
Conclusion
This report provides further evidence that retroviral infection
promotes pro-growth survival phenotypes in human cells during
cellular transformation by causing perturbations in redox home-
ostasis that can be partially reversed by treatment with scavengers
of O2 and H2O2.
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